XML 34 R9.htm IDEA: XBRL DOCUMENT
v3.23.3

Operating Segments | 9 Months Ended
--- | ---
Sep. 30, 2023
Operating Segments [Abstract] |
Operating Segments | Note 4:- Operating Segments
| a. | General:
The company has two operating segments, as follows:
Proprietary Products | - | Development, manufacturing, sales and distribution of proprietary plasma-derived protein therapeutics.
Distribution | - | Distribute imported drug products in Israel, which are manufactured by third parties.
| b. | Reporting on operating segments:
|  | Proprietary Products |  |  | Distribution |  |  | Total |
|  | U.S Dollars in thousands |
|  | Unaudited |
Nine months period ended September 30, 2023 |  |  |  |  |  |  |  |  |
Revenues |  | $ | 86,437 |  |  | $ | 19,650 |  |  | $ | 106,087 |
Gross profit |  | $ | 38,574 |  |  | $ | 2,504 |  |  | $ | 41,078 |
Unallocated corporate expenses |  |  |  |  |  |  |  |  |  |  | (33,790 | )
Finance expenses, net |  |  |  |  |  |  |  |  |  |  | (3,883 | )
Income before taxes on income |  |  |  |  |  |  |  |  |  | $ | 3,405 |
|  | Proprietary Products |  |  | Distribution |  |  | Total |
|  | U.S Dollars in thousands |
|  | Unaudited |
Nine months period ended September 30, 2022 |  |  |  |  |  |  |  |  |
Revenues |  | $ | 67,198 |  |  | $ | 16,702 |  |  | $ | 83,900 |
Gross profit |  | $ | 29,342 |  |  | $ | 2,070 |  |  | $ | 31,412 |
Unallocated corporate expenses |  |  |  |  |  |  |  |  |  |  | (30,898 | )
Finance expenses, net |  |  |  |  |  |  |  |  |  |  | (5,719 | )
Income before taxes on income |  |  |  |  |  |  |  |  |  | $ | (5,205 | )
|  | Proprietary Products |  |  | Distribution |  |  | Total |
|  | U.S Dollars in thousands |
|  | Unaudited |
Three months period ended September 30, 2023 |  |  |  |  |  |  |  |  |
Revenues |  | $ | 31,436 |  |  | $ | 6,498 |  |  | $ | 37,934 |
Gross profit |  | $ | 13,989 |  |  | $ | 814 |  |  | $ | 14,803 |
Unallocated corporate expenses |  |  |  |  |  |  |  |  |  |  | (10,435 | )
Finance expenses, net |  |  |  |  |  |  |  |  |  |  | (1,072 | )
Income before taxes on income |  |  |  |  |  |  |  |  |  | $ | 3,296 |
|  | Proprietary Products |  |  | Distribution |  |  | Total |
|  | U.S Dollars in thousands |
|  | Unaudited |
Three months period ended September 30, 2022 |  |  |  |  |  |  |  |  |
Revenues |  | $ | 25,580 |  |  | $ | 6,637 |  |  | $ | 32,217 |
Gross profit |  | $ | 12,429 |  |  | $ | 441 |  |  | $ | 12,870 |
Unallocated corporate expenses |  |  |  |  |  |  |  |  |  |  | (10,308 | )
Finance expenses, net |  |  |  |  |  |  |  |  |  |  | (2,068 | )
Income before taxes on income |  |  |  |  |  |  |  |  |  | $ | 494 |
| b. | Reporting on operating segments:
|  | Proprietary Products |  |  | Distribution |  |  | Total |
|  | U.S Dollars in thousands |
|  | Audited |
Year Ended December 31, 2022 |  |  |  |  |  |  |  |  |
Revenues |  | $ | 102,598 |  |  | $ | 26,741 |  |  | $ | 129,339 |
Gross profit |  | $ | 44,369 |  |  | $ | 2,334 |  |  | $ | 46,703 |
Unallocated corporate expenses |  |  |  |  |  |  |  |  |  |  | (42,171 | )
Finance expenses, net |  |  |  |  |  |  |  |  |  |  | (6,791 | )
Income before taxes on income |  |  |  |  |  |  |  |  |  | $ | (2,259 | )
| c. | Reporting on operating segments by geographic region:
|  | Nine months period ended September 30, 2023 |
|  | Proprietary Products |  |  | Distribution |  |  | Total |
|  | U.S Dollars in thousands |
|  | Unaudited |
Geographical markets |  |  |  |  |  |  |  |  |
U.S.A and North America |  | $ | 62,150 |  |  | $ | - |  |  | $ | 62,150 |
Israel |  |  | 3,119 |  |  |  | 19,650 |  |  |  | 22,769 |
Europe |  |  | 6,724 |  |  |  | - |  |  |  | 6,724 |
Latin America |  |  | 10,365 |  |  |  | - |  |  |  | 10,365 |
Asia |  |  | 3,958 |  |  |  | - |  |  |  | 3,958 |
Others |  |  | 121 |  |  |  | - |  |  |  | 121 |
|  | $ | 86,437 |  |  | $ | 19,650 |  |  | $ | 106,087 |
| c. | Reporting on operating segments by geographic region:
|  | Nine months period ended September 30, 2022 |
|  | Proprietary Products |  |  | Distribution |  |  | Total |
|  | U.S Dollars in thousands |
|  | Unaudited |
Geographical markets |  |  |  |  |  |  |  |  |
U.S.A and North America. |  | $ | 52,866 |  |  | $ | - |  |  | $ | 52,866 |
Israel |  |  | 3,631 |  |  |  | 16,702 |  |  |  | 20,333 |
Europe |  |  | 2,192 |  |  |  | - |  |  |  | 2,192 |
Latin America |  |  | 5,301 |  |  |  | - |  |  |  | 5,301 |
Asia |  |  | 2,665 |  |  |  | - |  |  |  | 2,665 |
Others |  |  | 543 |  |  |  | - |  |  |  | 543 |
|  | $ | 67,198 |  |  | $ | 16,702 |  |  | $ | 83,900 |
|  | Three months period ended September 30, 2023 |
|  | Proprietary Products |  |  | Distribution |  |  | Total |
|  | U.S Dollars in thousands |
|  | Unaudited |
Geographical markets |  |  |  |  |  |  |  |  |
U.S.A and North America. |  | $ | 25,294 |  |  | $ | - |  |  | $ | 25,294 |
Israel |  |  | 1,017 |  |  |  | 6,498 |  |  |  | 7,515 |
Europe |  |  | 3,280 |  |  |  | - |  |  |  | 3,280 |
Latin America |  |  | 328 |  |  |  | - |  |  |  | 328 |
Asia |  |  | 1,479 |  |  |  | - |  |  |  | 1,479 |
Others |  |  | 38 |  |  |  | - |  |  |  | 38 |
|  | $ | 31,436 |  |  | $ | 6,498 |  |  | $ | 37,934 |
|  | Three months period ended September 30, 2022 |
|  | Proprietary Products |  |  | Distribution |  |  | Total |
|  | U.S Dollars in thousands |
|  | Unaudited |
Geographical markets |  |  |  |  |  |  |  |  |
U.S.A and North America. |  | $ | 20,597 |  |  | $ | - |  |  | $ | 20,597 |
Israel |  |  | 1,377 |  |  |  | 6,637 |  |  |  | 8,014 |
Europe |  |  | 750 |  |  |  | - |  |  |  | 750 |
Latin America |  |  | 1,775 |  |  |  | - |  |  |  | 1,775 |
Asia |  |  | 767 |  |  |  | - |  |  |  | 767 |
Others |  |  | 314 |  |  |  | - |  |  |  | 314 |
|  | $ | 25,580 |  |  | $ | 6,637 |  |  | $ | 32,217 |
|  | Year ended December 31, 2022 |
|  | Proprietary Products |  |  | Distribution |  |  | Total |
|  | U.S Dollars in thousands |
|  | Audited |
Geographical markets |  |  |  |  |  |  |  |  |
U.S.A and North America |  | $ | 75,851 |  |  | $ | - |  |  | $ | 75,851 |
Israel |  |  | 5,290 |  |  |  | 26,741 |  |  |  | 32,031 |
Europe |  |  | 5,277 |  |  |  | - |  |  |  | 5,277 |
Latin America |  |  | 11,294 |  |  |  | - |  |  |  | 11,294 |
Asia |  |  | 4,581 |  |  |  | - |  |  |  | 4,581 |
Others |  |  | 305 |  |  |  | - |  |  |  | 305 |
|  | $ | 102,598 |  |  | $ | 26,741 |  |  | $ | 129,339 |

X
- Definition The entire disclosure for operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Section Disclosure -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI -URIDate 2023-03-23 + Details
Name: | ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfOperatingSegmentsAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration